Suppr超能文献

非处方获取激素避孕方法:ACOG 委员会意见,第 788 号。

Over-the-Counter Access to Hormonal Contraception: ACOG Committee Opinion, Number 788.

出版信息

Obstet Gynecol. 2019 Oct;134(4):e96-e105. doi: 10.1097/AOG.0000000000003473.

Abstract

Barriers to access are one reason for inconsistent or nonuse of contraception. The requirement for a prescription can be an obstacle for some contraceptive users. Several studies have demonstrated that women are capable of using self-screening tools to determine their eligibility for hormonal contraceptive use. Pelvic and breast examinations, cervical cancer screening, and sexually transmitted infection screening are not required before initiating hormonal contraception and should not be used as reasons to deny access to hormonal contraception. Also, a plan to improve access to hormonal contraception should address cost issues. Pharmacist-provided contraception may be a necessary intermediate step to increase access to contraception, but over-the-counter access to hormonal contraception should be the ultimate goal. The American College of Obstetricians and Gynecologists supports over-the-counter access to hormonal contraception without age restrictions. This Committee Opinion has been updated to expand the focus of over-the-counter contraception to include oral contraceptive pills, vaginal rings, the contraceptive patch, and depot medroxyprogesterone acetate, to address the role of pharmacist-provided contraception, and to provide recommendations for individuals younger than 18 years.

摘要

获得避孕措施的障碍是导致避孕措施使用不一致或不使用的原因之一。一些避孕措施需要处方,这对一些使用者来说可能是一个障碍。多项研究表明,女性有能力使用自我筛查工具来确定自己是否有资格使用激素避孕措施。在开始使用激素避孕措施之前,不需要进行盆腔和乳房检查、宫颈癌筛查和性传播感染筛查,也不应将这些检查作为拒绝提供激素避孕措施的理由。此外,改善获得激素避孕措施的计划应解决成本问题。药剂师提供的避孕措施可能是增加避孕措施可及性的必要中间步骤,但非处方获得激素避孕措施应该是最终目标。美国妇产科医师学会支持在无年龄限制的情况下非处方获得激素避孕措施。本委员会意见已更新,将非处方避孕措施的重点扩大到包括口服避孕药、阴道环、避孕贴和醋酸甲羟孕酮长效注射剂,以解决药剂师提供避孕措施的作用,并为 18 岁以下人群提供建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验